[Congressional Record Volume 149, Number 119 (Wednesday, September 3, 2003)]
[Senate]
[Page S11034]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

      By Mr. DeWINE:
  S. 1579. A bill to provide for the continuation of the Pediatric 
Research Initiative; to the Committee on Health, Education, Labor, and 
Pensions.
  Mr. DeWINE. Mr. President, I ask unanimous consent that the text of 
the bill be printed in the Record.
  There being no objection, the bill was ordered to be printed in the 
Record, as follows:


                                S. 1579

         Be it enacted by the Senate and House of Representatives 
     of the United States of America in Congress assembled,

     SECTION 1. PEDIATRIC RESEARCH INITIATIVE.

         The Director of the National Institutes of Health in 
     implementing the Pediatric Research Initiative under section 
     409D of the Public Health Service Act (42 U.S.C. 284h), 
     shall--
         (1) continue the Initiative and emphasize the importance 
     of pediatric research, particularly translational research; 
     and
         (2) not later than January of 2004, continue to report to 
     the Committee on Health, Education, Labor, and Pensions of 
     the Senate and the Committee on Energy and Commerce of the 
     House of Representatives on the status of the Pediatric 
     Research Initiative, including--
         (A) the extent of the total funds obligated to conduct or 
     support pediatric research across the National Institutes of 
     Health, including the specific support and research awards 
     allocated by the Office of the Director through the 
     Initiative;
         (B) the activities of the cross-institute committee on 
     pediatric research in assisting the Director in considering 
     requests for new or expanded pediatric research to be funded 
     through the Initiative;
         (C) how the Director plans to budget dollars toward the 
     Initiative for fiscal year 2004;
         (D) the amount the Director has expended to implement the 
     Initiative since the enactment of the Initiative;
         (E) the status of any research conducted as a result of 
     the Initiative;
         (F) whether that research is translational research or 
     clinical research;
         (G) how the Initiative interfaces with the Off-Patent 
     research fund of the National Institutes of Health; and
         (H) any recommended modifications that Congress should 
     consider in the authority or structure of the Initiative 
     within the National Institutes of Health for the optimal 
     operation and success of the Initiative.
                                 ______